Novo Nordisk reported second quarter earnings a week after revising its 2025 outlook down on slower GLP-1 sales.

In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...

The Trump administration is planning to pilot covering weight loss drugs. A longtime healthcare exec moves to a strategic advisory role at General Catalyst.

Amgen stock dropped Wednesday despite a strong second quarter as investors look ahead to the next weight-loss readouts.

The post This One Test Will Tell You More About Your Heart Attack Risk appeared first on Katie Couric Media. As the Nicki ...

Eli Lilly's stock is lagging the S&P 500 since April, potentially allowing a catch-up trade if results impress. Medicare may ...

Eli Lilly and Company is gearing up for its second quarter earnings report this Thursday, before the market opens. The pharmaceutical giant has witnessed significant revenue boosts from its ...

CMS often withholds coverage for reimbursement, disrupting the natural flow of the market and hindering access to proven ...

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 4.4% in the afternoon session after the company ...